Immunopathogenesis of the multiple sclerosis lesion
Data up to Jan 2025
Total Citations Per Year
Abstract
References (50)
Two subsets of memory T lymphocytes with distinct homing potentials and effector functions
1999 • 5,659 citations
Axonal Transection in the Lesions of Multiple Sclerosis
1998 • 4,007 citations
Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination
2000 • 3,258 citations
Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4
1995 • 2,842 citations
CD4+CD25+ Immunoregulatory T Cells Suppress Polyclonal T Cell Activation In Vitro by Inhibiting Interleukin 2 Production
1998 • 2,658 citations
Cytotoxic T Lymphocyte–Associated Antigen 4 Plays an Essential Role in the Function of Cd25+Cd4+ Regulatory Cells That Control Intestinal Inflammation
2000 • 2,211 citations
Axonal damage in acute multiple sclerosis lesions
1997 • 1,543 citations
Intramuscular Interferon Beta-1A Therapy Initiated during a First Demyelinating Event in Multiple Sclerosis
2000 • 1,497 citations
Update on the Autoimmune Pathology of Multiple Sclerosis: B-Cells as Disease-Drivers and Therapeutic Targets
2015 • 1,440 citations
Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord
1999 • 1,212 citations
T‐lymphocyte entry into the central nervous system
1991 • 1,168 citations
Clonal Expansions of Cd8+ T Cells Dominate the T Cell Infiltrate in Active Multiple Sclerosis Lesions as Shown by Micromanipulation and Single Cell Polymerase Chain Reaction
2000 • 918 citations
Acute axonal injury in multiple sclerosis: Correlation with demyelination and inflammation
2000 • 889 citations
Identification of autoantibodies associated with myelin damage in multiple sclerosis
1999 • 881 citations
Encephalitogenic potential of the myelin basic protein peptide (amino acids 83–99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand
2000 • 805 citations
The adhesion molecule and cytokine profile of multiple sclerosis lesions
1995 • 761 citations
Diabetes induced by Coxsackie virus: Initiation by bystander damage and not molecular mimicry
1998 • 669 citations
Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b
2000 • 656 citations
Plaque-associated expression of human herpesvirus 6 in multiple sclerosis.
1995 • 611 citations
The prognostic value of brain MRI in clinically isolated syndromes of the CNS. A 10-year follow-up
1998 • 483 citations
Accumulation of hypointense lesions ("black holes") on T 1 spin-echo MRI correlates with disease progression in multiple sclerosis
1996 • 451 citations
A quantitative analysis of oligodendrocytes in multiple sclerosis lesions
1999 • 445 citations
Magnetization transfer changes in the normal appering white matter precede the appearance of enhancing lesions in patients with multiple sclerosis
1998 • 393 citations
The pathogenesis of lesions and normal-appearing white matter changes in multiple sclerosis: A serial diffusion MRI study
2000 • 314 citations
Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis
1999 • 297 citations
Oligodendrocyte progenitors are present in the normal adult human CNS and in the lesions of multiple sclerosis
1998 • 285 citations
Decreased dependence of myelin basic protein-reactive T cells on CD28-mediated costimulation in multiple sclerosis patients. A marker of activated/memory T cells.
1998 • 267 citations
Detection of MHC class II-antigens on macrophages and microglia, but not on astrocytes and endothelia in active multiple sclerosis lesions
1994 • 258 citations
Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumine–enhancing magnetic resonance imaging lesions
1993 • 237 citations
Comparison of MS clinical phenotypes using conventional and magnetization transfer MRI
1999 • 234 citations
Homing to central nervous system vasculature by antigen-specific lymphocytes. I. Localization of 14C-labeled cells during acute, chronic, and relapsing experimental allergic encephalomyelitis.
1990 • 234 citations
Spinal cord atrophy and disability in MS
1998 • 230 citations
Oligodendrocyte survival, loss and birth in lesions of chronic-stage multiple sclerosis
2000 • 220 citations
Progressive cerebral atrophy in MS
2000 • 218 citations
Differential adhesion molecule requirements for immune surveillance and inflammatory recruitment
2000 • 218 citations
Identification of candidate T-cell epitopes and molecular mimics in chronic Lyme disease
1999 • 217 citations
Expansion of Autoreactive T Cells in Multiple Sclerosis Is Independent of Exogenous B7 Costimulation
1998 • 193 citations
Resistance to Apoptosis and Elevated Expression of Bcl-2 in Clonally Expanded CD4+CD28− T Cells from Rheumatoid Arthritis Patients
1998 • 192 citations
In vivo evidence for axonal dysfunction remote from focal cerebral demyelination of the type seen in multiple sclerosis
1999 • 181 citations
Absolute quantification of brain metabolites by proton magnetic resonance spectroscopy in normal-appearing white matter of multiple sclerosis patients
1999 • 162 citations
In Situ Tolerance within the Central Nervous System as a Mechanism for Preventing Autoimmunity
2000 • 161 citations
Predictable TCR antigen recognition based on peptide scans leads to the identification of agonist ligands with no sequence homology.
1998 • 156 citations
Viral Infection of Transgenic Mice Expressing a Viral Protein in Oligodendrocytes Leads to Chronic Central Nervous System Autoimmune Disease
1996 • 140 citations
Cutting Edge: Predictable TCR Antigen Recognition Based on Peptide Scans Leads to the Identification of Agonist Ligands with No Sequence Homology
1998 • 118 citations
Multisequence MRI in clinically isolated syndromes and the early development of MS
1999 • 114 citations
Naive T lymphocytes traffic to inflamed central nervous system, but require antigen recognition for activation
2000 • 101 citations
Spatial mapping of T2 and gadolinium-enhancing T1 lesion volumes in multiple sclerosis: evidence for distinct mechanisms of lesion genesis?
1999 • 98 citations
Increased numbers of CCR5+ interferon-?- and tumor necrosis factor-?-secreting T lymphocytes in multiple sclerosis patients
2000 • 89 citations
Insulin-like growth factor-I given subcutaneously reduces clinical deficits, decreases lesion severity and upregulates synthesis of myelin proteins in experimental autoimmune encephalomyelitis
1996 • 64 citations
A high‐resolution three‐dimensional T1‐weighted gradient echo sequence improves the detection of disease activity in multiple sclerosis
1996 • 48 citations